Bladder cancer — all decisions

The Board of Veterans' Appeals granted service connection for the Veteran's bladder cancer, finding that it was caused by his active-duty military service.

The Board granted service connection for bladder cancer, finding that the evidence is at least in approximate balance as to whether the Veteran's bladder cancer is etiologically related to his service.

The Board granted service connection for bladder cancer, finding that the Veteran's exposure to jet fuel during service was related to his condition.

The Board granted an effective date of October 2, 2018, for the grant of service connection for status post nephroureterectomy due to bladder cancer based on the Veteran's continuous pursuit of the claim and evidence linking the condition to in-service exposure.

The Board remands the claims for a higher rating for respiratory conditions and service connection for kidney, prostate, bladder cancer, and obstructive sleep apnea due to outstanding medical records and inadequate VA opinions.

The Board denied the veteran's claims for a higher disability rating, an earlier effective date for service connection of erectile dysfunction, and an earlier effective date for special monthly compensation based on loss of use of a creative organ.

The veteran's appeal for a higher rating for bladder cancer was dismissed due to the untimely filing of the Board Appeal request.

The Board remands the service connection claim for bladder cancer due to a pre-decisional duty to assist error, as there are no adequate medical opinions in the record.

The Veteran's claim for a compensable rating for service-connected bladder cancer was denied as the evidence did not show that his condition caused any symptoms warranting a compensable evaluation.

The Board granted service connection for coronary artery disease, prostate cancer, and bladder cancer due to presumed exposure to herbicide agents during the Veteran's service in the Korean DMZ.

The Board denied higher ratings for prostate cancer, ED, and hypertension but granted a 10 percent initial rating for hypertension. Service connection was denied for lung cancer, bladder cancer, hyperglycemia, and COPD.

The Veteran is granted an initial 20 percent evaluation for bladder cancer based on increased urinary frequency.

The Board remands the claims for service connection for colon and bladder cancers for further development, including an examination and opinion.

The Veteran was granted a 100 percent rating for bladder cancer from August 10, 2022 through September 2022 due to the cessation of treatment following the enactment of the PACT Act. However, a compensable rating for residuals of bladder cancer is denied.

The Board granted service connection for bladder cancer and related conditions, but denied service connection for anxiety.

The Board denied an earlier effective date for service connection for bladder cancer and special monthly compensation based on the need for aid and attendance of another person.

The Board granted an effective date of May 23, 2024, for the award of a 40 percent evaluation for bladder cancer and basic eligibility to Dependents' Educational Assistance.

The Board granted service connection for bladder cancer and prostate cancer, as the Veteran was presumed to have been exposed to herbicide agents during his service near the Korean DMZ.

The veteran was granted a 10 percent disability rating for bladder cancer from March 1, 2023, to February 29, 2024.

The Veteran was granted an initial 100 percent rating for residuals of bladder cancer and prostate cancer from November 28, 2011 through September 4, 2012 and April 1, 2013 through February 27, 2014, and an effective date of November 28, 2011 for the award of eligibility for DEA benefits under 38 U.S.C. Chapter 35.